CUE Stock Analysis: Buy, Sell, or Hold?
CUE - Cue Biopharma, Inc.
$12.46
-5.48 (-30.54%)
▼
5d:
+1758.96%
30d:
+5102.59%
90d:
+3088.68%
WAIT
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 12, 2026
12d
Get Alerted When CUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CUE is 72.5% above its trading range ($7.22). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CUE is 72.5% above its trading range ($7.22). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CUE is currently trading at $12.46, which is considered extended relative to its 30-day fair value range of $-2.90 to $7.22.
Technical Outlook: Technically, CUE is showing sideways momentum. Immediate support is located at $0.42, while resistance sits at $30.97. Short-term momentum is weak, with the stock down 30.5% recently.
Market Sentiment: CUE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $120.00 (+863.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CUE is showing sideways momentum. Immediate support is located at $0.42, while resistance sits at $30.97. Short-term momentum is weak, with the stock down 30.5% recently.
Market Sentiment: CUE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $120.00 (+863.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-2.90 -
$7.22
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
42.1%
All Signals
- BEARISH: Price significantly overextended (+72.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-30.5%)
- BULLISH: Trading 863.5% below Wall St target ($120.00)
Trading Range Analysis
30-Day Trading Range
$-2.90 -
$7.22
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.42
Resistance Level
$30.97
Current Trend
Sideways
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.69
Wall Street Target
$120.00
(+863.5%)
Revenue Growth (YoY)
1292.3%
Profit Margin
-96.9%
Share & Embed Analysis
Last updated: April 29, 2026 6:53 AM ET
Data refreshes hourly during market hours. Next update: 7:53 AM
Data refreshes hourly during market hours. Next update: 7:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 52 HOLD |
